Editorial Board ::: Current Drug Metabolism

ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)

Volume 17, 10 Issues, 2016

Download PDF Flyer

Current Drug Metabolism

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 125th of 289 in Biochemistry & Molecular Biology
  • 82nd of 254 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Michael Sinz
Bristol Myers Squibb
Wallingford, CT

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.847
5 - Year: 3.222

Editorial Board


Michael Sinz
Bristol Myers Squibb
Wallingford, CT


Amin Rostami-Hodjegan
University of Manchester

Associate Editor(s):

Region: USA
Albert P. Li
In Vitro ADMET Laboratories
Columbia, MD

Shufeng Zhou
University of South Florida
Florida, FL

Region: Europe
Aleksandra Galetin
University of Manchester

Nico P.E. Vermeulen
Vrije Universiteit Amsterdam
The Netherlands

Region: Asia
Kenichi Fujita ()
Showa University

Lee Jia
Fuzhou University

Jasminder Sahi
Sanofi-Aventis Shanghai

Regional Editor(s):

Region: Middle East
Mohammad Amjad Kamal
King Abdulaziz University
Saudi Arabia

Editorial Board Members:

S. Akhter
LE STUDIUM Loire Valley Institute for Advanced Studies

M. Balazy
New York Medical College
Valhalla, NY

G. Bowers
Research Triangle Park, NC

J. Cashman
Human BioMol. Research Inst
San Diego, CA

R. Franklin
Array Biopharma Inc
Boulder, CO

M.J. Gómez-Lechón
Hospital La Fe

M. Hu
University of Houston College of Pharmacy
Houston, TX

J.M. Hutzler
Q2 Solutions
Indianapolis, IN

K. Kassahun
Merck & Co
West Point, PA

C. Liu
Tianjin Institute of Pharmaceutical Research

C. Prakash
CP Pharma Consulting Principal, Drug Metabolism and Pharmacokinetics

T. Rushmore
Merck Research Laboratories
West Point, PA

P.C. Smith
University of North Carolina
Chapel Hill, NC

J. Turgeon
Université de Montréal
Montréal, Québec

B. Wong
Wong DMPK Consulting, LLC
Redwood City, CA

W. Xie (Biography
W. Xie

Dr. Xie received his MD from the Peking University Health Science Center and PhD from University of Alabama at Birmingham. He is Professor of Pharmaceutical Sciences and Koslow Endowed Chair in Pharmaceutical Sciences at the University of Pittsburgh School of Pharmacy. Dr. Xie has published more than 150 papers and book chapters. He has been invited to speak for over 160 research conferences and departmental seminars. Dr. Xie is also editorial board member for Molecular Pharmacology, Drug Metabolism and Disposition, and Endocrinology.


University of Pittsburgh
Pittsburgh, PA

T.B. Andersson (Biography
T.B. Andersson

Tommy B. Andersson (PhD) is a senior principal scientist and Science Director at DMPK cardiovascular and metabolic diseases, AstraZeneca R&D, Gothenburg Sweden, since 2012. He is also appointed associate professor at Department of Physiology and Pharmacology, Section of Pharmacogenetics Karolinska Institutet, Stockholm since 2003. He has over 20 years scientific, management and project experience in several positions within the pharmaceutical industry and academia covering drug metabolism and pharmacokinetics as well as hepatotoxicity in projects from early drug discovery to life cycle management. He is the author of more than 150 peer reviewed scientific publications.


AstraZeneca R&D Gothenburg Mİlndal

K. Beaumont
Pfizer Global Research and Development

J. Caldwell
University of Liverpool

C. Chen (Biography
C. Chen

Dr. Chen and obtained her Ph.D. degree in Biomedical engineering from Huazhong University of Science and Technology of China (1996). She is one of the earliest researchers in the field of nanosafety in China. Dr. Chen currently is a principal investigator at CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety in National Center for Nanoscience and Technology of China. She has authored/co-authored over 150 peer-reviewed papers /book chapters, has more than ten issued patents and finished one ISO standard. She has been awarded the Second Prize of the National Natural Science Awards (2012), China Outstanding Young Female Scientists Awards (2014) and the National Science Fund for Distinguished Young Scholars (2014).


National Center for Nanoscience and Technology
Beijing, P. R.

E.M.J. Gillam
The University of Queensland
St. Lucia

H. Hao (Biography
H. Hao

Dr. Hao obtained his Ph.D. degree in Drug Metabolism and Pharmacokinetics from China Pharmaceutical University. Currently Dr. Hao is a professor and the dean of School of Pharmacy in China Pharmaceutical University. His research mainly covers the molecular mechanisms of drug disposition and metabolic regulation guided target discovery. He has published more than 120 scientific publications and is currently an editor of this journal.


China Pharmaceutical University

W.G. Humphreys
Bristol-Myers Squibb
Princeton, NJ

M. Kajbaf (Biography
M. Kajbaf

Dr Mahmud Kajbaf holds a Ph.D. from the University of London, King’s College, Biopharmacy Department in the area of drug metabolism and MSc from Aston University, Birmingham.

Currently Dr Kajbaf is Senior Scientist at Aptuit. He has received several awards and honors, such as: Aptuit CEO Excellence Award, GlaxoSmithKline the psychiatry CEDD Leadership Team Award. He is also on the editorial board for several journals. He has published over 33 research articles related to drug metabolism, in vivo-in vitro correlation, drug-drug interaction, HPLC, NMR and mass spectrometry.


GlaxoSmithKline S.p.A., Fleming

R. Kim
University of Western Ontario
London, ON

A.E. Mutlib
Wyeth Research
Collegeville, PA

M.S. Roberts
University of South Australia

J.F. Rusling
University of Connecticut
Storrs, CT

M. Soars
Bristol-Myers Squibb
Wallingford, CT

M. Ulgen
Acibadem University

B. Wu
Jinan University

H. Yamazaki (Biography
H. Yamazaki

Dr. Hiroshi Yamazaki has been Professor of Laboratory of Drug Metabolism and Pharmacokinetics at Showa Pharmaceutical University, Tokyo, Japan since 2005. He received his PhD degree from Osaka University in Japan and was trained at Vanderbilt University, TN, USA in 1994. He was a scientist at Osaka Prefectural Institute of Public Health and an Associate Professor of Kanazawa (1998) and Hokkaido (2001) University. He has authored over 340 publications and has been the recipient of the Japanese Society for the Study of Xenobiotics (JSSX) Award and Fellow. He is a member of several editorial committees and the JSSX President-elect (2016-2017).


Showa Pharma University

S.K. Balani (Biography
S.K. Balani

Suresh Balani is in Drug Metabolism and Pharmacokinetics department at Takeda Pharmaceuticals International Co. in Cambridge, MA, currently directing drug development in Gastroenterology and Central Nervous System portfolios. He received his Ph.D. at Queen's University of Belfast, Northern Ireland, U.K., and subsequently worked at National Institutes of Health in Bethesda, MD; Merck Research Labs at West Point, PA; and DuPont Pharmaceuticals at Delaware. He has published over 100 scientific papers and abstracts, and has 10 patents. He is on the Editorial Board of Current Drug Metabolism.


Takeda Pharmaceuticals International Company
Cambridge, MA

I. Blair
University of Pennsylvania
Philadelphia, PA

D. Capone
University of Naples Federico II

L. Di (Biography
L. Di

Dr. Li Di has about 20 years of experience in the pharmaceutical indus¬try including Pfizer, Wyeth and Syntex. She is currently a research fellow at Pfizer, Groton, CT. Her research interests include the areas of drug metabo¬lism, pharmacokinetics, drug-drug interactions, absorption, transporters, and blood–brain barrier. She has over 120 publications including two books and presented over 80 invited lectures. She is a recipient of the Thomas Alva Edison Patent Award, the New Jersey Association for Biomedical Research Outstanding Woman in Science Award, the Wyeth President’s Award and Peer Award for Excellence.


Pfizer Inc.
Groton, CT

H. Glatt
German Institute of Human Nutrition (DIfE)

P.F. Hollenberg
University of Michigan
Ann Arbor, MI

T. Hussain
University of Houston
Houston, TX

E. Kantharaj
R & D Technical, D3, A*STAR

J. Kirchheiner
University of Ulm

K.B. Park (Biography
K.B. Park

Professor Kevin Park is currently Professor of Pharmacology and Head of the Institute of Translational Medicine at the University of Liverpool. Professor Park is a Fellow of the Royal College of Physicians, a Fellow of the Academy of Medical Sciences and also a Commissioner on Human Medicines. The over-riding theme of his work is bringing “molecule–to-man” and back again, to enable the prediction of adverse drug reactions based on the chemical structure of the drug and the identification of susceptible individuals. This work has been expanded by using pharmacogenomics and toxicogenomics to link findings in patients to the chemical structure of the drug. The group are now in a position to provide solutions to adverse drug reactions through research in two areas: 1) improved drug design and 2) the delivery of individualised medicines.


University of Liverpool

A.D. Rodrigues (Biography
A.D. Rodrigues

Dr. Rodrigues serves as Research Fellow at Pfizer Groton, CT USA. He earned his PhD at Surrey University (Guildford, Surrey, England) and has authored 20 book chapters, over 120 peer-reviewed manuscripts, and presented at over 60 symposia. In 2009, he was inducted as AAPS Fellow. Dr. Rodrigues has served on the Editorial Board of numerous drug metabolism journals, is currently Associate Editor of Xenobiotica, and has edited/co-edited 4 books related to drug interactions and drug metabolism. Dr. Rodrigues is adjunct professor at the University of Rhode Island, School of Pharmacy.


Pfizer Inc.
Groton, CT

M.B. Silber
Roche Pharmaceuticals
Palo Alto, CA

B.L. Tekwani
University of Mississippi
Oxford, MS

H. Wang (Biography
H. Wang

Dr. Hongbing Wang, Professor & Program Chair, Experimental and Translational Therapeutics, Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy. Dr. Wang’s research interests including investigation of the molecular mechanisms that govern nuclear receptor‐mediated induction of metabolizing enzymes and drug transporters in humans, metabolism‐based drugdrug interactions, and drug‐induced liver toxicity.


University of Maryland School of Pharmacy
Baltimore, MD

J. Xiao (Biography
J. Xiao

Dr. Xiao obtained a doctorate (Ph.D.) in Nutrition from Okayama Prefectural University (Japan) in 2009 and worked as a Humboldtian in Universität Würzburg (Germany) supported by AvH Foundation. Currently Dr. Xiao is an Assistant Professor in University of Macau and a Distinguished Professor in Fujian Agriculture & Forestry University (China). He has published more than 120 scientific publications and is named a 2016 Highly Cited Researcher by Thomson Reuters. Dr. Xiao is currently the Editorial Board Member of Anti-Cancer Agents in Medicinal Chemistry, Frontiers in Pharmacology, Industrial Crops and Products, Phytochemical Analysis, Molecules, Journal of Berry Research, Phytomedicine, Pharmacognosy Magazine.


University of Macau

Reviewer Panel:

1. J.A.G. Agúndez (Spain)
4. E. Chan (Singapore)
7. B. Chowbay (Singapore)
10. Z. Dvorak (Czech Republic)
13. L.L. Gan (USA)
16. J. Hakkola (Finland)
19. P. Honkakoski (Finland)
22. Z.-Yi. Hu (USA)
25. Y. Jounaidi (USA)
28. T. Károly (Hungary)
31. M. Kranendonk (Portugal)
34. P.H. Marathe (USA)
37. A. McLachlan (Australia)
40. A. Nishikawa (Japan)
43. E. Schuetz (USA)
46. Y.-F. Ueng (Taiwan)
49. E.L. Woodahl (USA)
52. C.-H. Yun (South Korea)
2. P. Anzenbacher (Czech Republic)
5. K.-C. Cheng (USA)
8. C. Collins (USA)
11. A. El-Kadi (Canada)
14. K. Grime (UK)
17. N. Helsby (New Zealand)
20. B. Houston (UK)
23. F. Innocenti (USA)
26. A.S. Kalgutkar (USA)
29. R.A. Kemper (USA)
32. J. Lambert (USA)
35. F. Martel (Portugal)
38. R.P. Meyer (Germany)
41. A. Palotas (Hungary)
44. M.-R. Shiran (Iran)
47. K. Venkatakrishnan (USA)
50. Z Yan (USA)
53. J.Y. Zhang (China)
3. D. Brian (USA)
6. M. Chetty (Australia)
9. M.T. Donato (Spain)
12. D. Fuchs (Austria)
15. J. Gu (China)
18. N. Hewitt (Germany)
21. M. Hu (USA)
24. H. Jeong (USA)
27. M.A. Kamal (Saudi Arabia)
30. G.M. Kirby (Canada)
33. M.-C. Liu (USA)
36. H.H. Maurer (Germany)
39. B. Moorthy (USA)
42. J. Sahi (USA)
45. W. Tang (USA)
48. B. Wong (USA)
51. A.M. Yu (USA)

Related Journals

Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science